Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.6400 (1.96%) ($10.6400 - $10.6400) on Mon. Jan. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.71% (three month average) | RSI | 40 | Latest Price | $10.6400(1.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(37%) XBI(32%) IBB(29%) SDY(27%) IFRA(25%) | Factors Impacting BCRX price | BCRX will decline at least -1.855% in a week (0% probabilities). VIXM(-17%) UUP(-10%) VXX(-7%) TBT(-1%) SMH(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.855% (StdDev 3.71%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.48(-104.51%) | Resistance Level | $10.79 | 5 Day Moving Average | $10.24(3.91%) | 10 Day Moving Average | $10.28(3.5%) | 20 Day Moving Average | $10.79(-1.39%) | To recent high | -24.2% | To recent low | 6.5% | Market Cap | $1.877b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |